Skip to content

Depression research published in 2018

Page 6 of 10: studies 101 to 120 of 186, newest first. Back to the depression overview

Studies

Study protocol of a multicenter randomized controlled trial of mindfulness training to reduce burnout and promote quality of life in police officers: the POLICE study.

BMC Psychiatry May 25, 2018 Marcelo Trombka, Marcelo Demarzo, Daniel Campos Bacas et al.

Background: Police officers experience a high degree of chronic stress. Policing ranks among the highest professions in terms of disease and accident rates. Mental health is particularly impacted, evidenced by elevated rates of burnout, anxiety and depression, and poorer quality of life than the general public. Mindfulness training has been shown to reduce stress, anxiety, burnout and promote...

Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide

F1000Research May 24, 2018 Ronald S. Duman 203 citations

Therapeutic medications for the treatment of depression have serious limitations, particularly delayed onset and low rates of efficacy. However, the discovery that a single subanesthetic dose of ketamine, a glutamate NMDA receptor channel blocker, can produce a rapid (within hours) antidepressant response that is sustained (about 1 week), even in patients considered treatment-resistant, has...

Relationships among mindfulness, anxiety and depression in surface warship soldiers: the mediating role of attentional control

Zhonghua xingwei yixue yu naokexue zazhi May 20, 2018 YU Yongju, Peng Li, Botao Liu et al. 1 citation

Objective To investigate the relationships between mindfulness, anxiety and depression in surface warship soldiers and the mediating role of attentional control. Methods Chinese versions of State-Trait Anxiety Inventory (STAI), Center for Epidemiologic Studies Depression Scale (CES-D), Attentional Control Scale (ACS) and the Five Facet Mindfulness Questionnaire (FFMQ) were used to survey 475...

A Review of the Mechanism of Antagonism of N-methyl-D-aspartate Receptor by Ketamine in Treatment-resistant Depression.

Cureus May 18, 2018 Yasar Sattar, John M Wilson, Ali M Khan et al.

The biochemical processes involved in depression go beyond serotonin, norepinephrine, and dopamine. The N-methyl-D-aspartate (NMDA) receptor has a major role in the neurophysiology of depression. Ketamine, one of the prototypical NMDA antagonists, works rapidly in controlling depressive symptoms, including acutely suicidal behavior, by just a single injection. Ketamine may rapidly increase the...

Differentiating Single and Multiple Suicide Attempters: What Nightmares Can Tell Us That Other Predictors Cannot.

Journal of Clinical Sleep Medicine May 15, 2018 Katrina J Speed, Christopher W Drapeau, Michael R Nadorff

Study objectives: Although nightmares have been associated with suicidal behavior beyond well-known risk factors, the association between nightmares and multiple suicide attempts remains largely unexplored. This study addressed this gap in the literature by examining whether nightmares differentiated between individuals who reported single versus multiple suicide attempts. The individual...

Cognitive and Neurophysiological Recovery Following Electroconvulsive Therapy: A Study Protocol

Frontiers in Psychiatry May 14, 2018 Ben J Palanca, Hannah R. Maybrier, Angela M. Mickle et al. 16 citations

Electroconvulsive therapy (ECT) employs the elective induction of generalizes seizures as a potent treatment for severe psychiatric illness. As such, ECT provides an opportunity to rigorously study the recovery of consciousness, reconstitution of cognition, and electroencephalographic (EEG) activity following seizures. Fifteen patients with major depressive disorder refractory to pharmacologic...

Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls

Frontiers in Psychiatry May 8, 2018 Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, Erick Allan Dos Santos Silva et al. 102 citations

Major depression is a highly prevalent mood disorder, affecting about 350 million people, and around 30% of the patients are resistant to currently available antidepressant medications. Recent evidence from a randomized controlled trial (RCT) supports the rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression. The aim of this study was to explore the effect...

Intranasal Esketamine Found to Rapidly Reduce Symptoms of Depression, Suicidality

Psychiatric News May 4, 2018 Mark Moran

If replication trials support these findings, safeguards will need to be established to guard against the risk of abuse while ensuring access to those patients who may benefit from esketamine. Intranasal esketamine appears to rapidly improve depression scores and measures of suicidality among depressed patients at imminent risk of suicide, according to a report published April 16 in AJP in...

The Effects of an Online Mindfulness Intervention on Perceived Stress, Depression and Anxiety in a Non-clinical Sample: A Randomised Waitlist Control Trial

Mindfulness May 2, 2018 Dawn Querstret, Mark Cropley, Chris Fife-Schaw

Mindfulness interventions have been shown to be effective for health and wellbeing, and delivering mindfulness programmes online may increase accessibility and reduce waiting times and associated costs; however, research assessing the effectiveness of online interventions is lacking. We sought to: (1) assess the effects of an online mindfulness intervention on perceived stress, depression and...

Mindfulness, coping strategies and mental health promotion among youths with depression and anxiety

International Journal of Applied Research May 1, 2018 Kirti .

The increasing prevalence of psychological distress among adolescents and young adults has been attributed to academic pressure, family conflict, socioeconomic inequalities, trauma, excessive social media use, discrimination, and other chronic stressors. When these stressors exceed an individual's coping capacity, maladaptive coping strategies such as avoidance, rumination, substance abuse,...

Neural effects of mindfulness-based interventions on patients with major depressive disorder: A systematic review.

Neuroscience & Biobehavioral Reviews May 2018 Philippe Vignaud, Clément Donde, Thouraya Sadki et al.

Growing evidence has suggested that mindfulness-based interventions (MBIs) could have beneficial effects on the acute phase of depression and on the prevention of depressive relapse or recurrence. Despite growing clinical interest, the effects of MBIs on brain functioning in patients with MDD remain unclear. The aim of this systematic review was to assess the changes in brain functioning...

Feasibility study to assess the effect of a brief mindfulness intervention for patients with chronic obstructive pulmonary disease: A randomized controlled trial.

Chronic respiratory disease April 24, 2018 Linda Perkins-Porras, Muhammad Riaz, Adeoba Okekunle et al.

Psychological distress is common among patients with chronic obstructive pulmonary disease (COPD). This study aimed to assess whether a 10-minute mindfulness intervention reduces distress and breathlessness, improves mood and increases mindfulness among hospital inpatients following acute exacerbation of COPD.Fifty patients were recruited following an acute admission. The immediate effects of a...

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

International Journal of Environmental Research and Public Health April 17, 2018 Carola Rong, Caroline Park, Joshua D. Rosenblat et al. 116 citations

OBJECTIVES: Extant evidence indicates that ketamine exerts rapid antidepressant effects in treatment-resistant depressive (TRD) symptoms as a part of major depressive disorder (MDD) and bipolar disorder (BD). The identification of depressed sub-populations that are more likely to benefit from ketamine treatment remains a priority. In keeping with this view, the present narrative review aims to...

Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression

ACS Chemical Neuroscience April 17, 2018 Lindsay P. Cameron, Charlie J. Benson, Lee E. Dunlap et al. 168 citations

Depression and anxiety disorders are debilitating diseases resulting in substantial economic costs to society. Traditional antidepressants often take weeks to months to positively affect mood and are ineffective for about 30% of the population. Alternatives, such as ketamine, a dissociative anesthetic capable of producing hallucinations, and the psychoactive tisane ayahuasca, have shown great...

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

American Journal of Psychiatry April 16, 2018 Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin et al. 666 citations

OBJECTIVE: The authors compared the efficacy of standard-of-care treatment plus intranasal esketamine or placebo for rapid reduction of symptoms of major depression, including suicidality, among individuals at imminent suicide risk. METHOD: In a double-blind, multicenter, proof-of-concept study, 68 participants were randomly assigned to receive esketamine (84 mg) or placebo twice weekly for 4...

Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales.

Journal of Affective Disorders April 15, 2018 Elizabeth D. Ballard, Julia S Yarrington, Cristan A Farmer et al.

Due to the heterogeneity of depressive symptoms-which can include depressed mood, anhedonia, negative cognitive biases, and altered activity levels-researchers often use a combination of depression rating scales to assess symptoms. This study sought to identify unidimensional constructs measured across rating scales for depression and to evaluate these constructs across clinical trials of a...

Mindfulness, Interpretation Bias, and Levels of Anxiety and Depression: Two Mediation Studies

Mindfulness April 12, 2018 Birgit Mayer, Marike G. Polak, Danielle Remmerswaal

In two studies, a possible mediation effect was tested of cognitive interpretation bias in the relation between respectively dispositional mindfulness and acceptance, on the one hand, and symptoms of depression and anxiety, on the other hand. An undergraduate student sample (N = 133; 86% female, Mage = 19.8) and a convenience community sample (N = 186; 66% female, Mage = 36.5) were examined by...

Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling

The International Journal of Neuropsychopharmacology April 10, 2018 Jessica R. Gilbert, Julia S Yarrington, Kathleen E. Wills et al. 58 citations

BACKGROUND: The glutamatergic modulator ketamine has rapid antidepressant effects in individuals with major depressive disorder and bipolar depression. Thus, modulating glutamatergic transmission may be critical to effectively treating depression, though the mechanisms by which this occurs are not fully understood. METHODS: This double-blind, crossover, placebo-controlled study analyzed data...

DOI: 10.1093/ijnp/pyy041 (opens in new tab) Ketamine Glutamatergic Depression economics Response inhibition +3

A Closer Look at Transcendence and Its Relationship to Mental Health.

Journal of Religion and Health April 1, 2018 John R Peteet

Experiences of transcendence can promote growth, creativity and altruism, but often exist in tension with critical thought and can feature problematically in certain mental disorders. Identification of the core elements in the experience of transcendence-suspending disbelief, being moved or inspired, surrendering oneself and identifying within a larger context, can clarify its relationship to...